Dextrain Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
Dextrain General Information
Description
Developer of neuroscience-based medical technology designed for the diagnosis and treatment of hand impairments. The company's platform utilizes high-resolution force measurement and machine learning analysis to improve neuro-recovery and independence, enabling neuro-rehabilitation clinics and stroke recovery patients to utilize personalized training exercises and precise dexterity assessments.
Contact Information
Website
www.dextrain.comCorporate Office
- 3 rue Ampère
- 91430 Igny
- France
Corporate Office
- 3 rue Ampère
- 91430 Igny
- France
Dextrain Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | 08-Dec-2021 | Completed | Generating Revenue |
Dextrain Signals
Dextrain Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| iPEPS-ICM | Accelerator/Incubator | Minority |
Dextrain FAQs
-
When was Dextrain founded?
Dextrain was founded in 2021.
-
Where is Dextrain headquartered?
Dextrain is headquartered in Igny, France.
-
What is the size of Dextrain?
Dextrain has 6 total employees.
-
What industry is Dextrain in?
Dextrain’s primary industry is Therapeutic Devices.
-
Is Dextrain a private or public company?
Dextrain is a Private company.
-
What is Dextrain’s current revenue?
The current revenue for Dextrain is .
-
Who are Dextrain’s investors?
iPEPS-ICM has invested in Dextrain.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process